NCT03103113

Brief Summary

The purpose of this study was to assess the relationship between infertility blood test results and outcomes of pregnancy and alive birth of women who underwent with or without intravenous immunoglobulin (IVIG) before in vitro fertilization.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2012

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2012

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

March 31, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 6, 2017

Completed
Last Updated

April 6, 2017

Status Verified

March 1, 2017

Enrollment Period

8 months

First QC Date

March 31, 2017

Last Update Submit

March 31, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • implantation rate

    sac and heart bit can be detected after embryo transfer

    6-8 weaks after last menstrual

Secondary Outcomes (1)

  • live birth rate

    live birth after pregnant

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients had underwent infertility blood test and in vitro fertilization treatment in Lee's women hospital

You may qualify if:

  • Patients had underwent both infertility blood test and IVF treatment in Lee's women hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infertility, Female

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Officials

  • Maw Sheng Lee

    Lee's Women Hospital, Taichung, Taiwan

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
institutional review board

Study Record Dates

First Submitted

March 31, 2017

First Posted

April 6, 2017

Study Start

April 30, 2012

Primary Completion

December 31, 2012

Study Completion

December 31, 2012

Last Updated

April 6, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will share

IPD can be shared after manuscription publication